Crescita Therapeutics (CTX) Competitors C$0.56 -0.03 (-5.08%) (As of 12/24/2024 01:21 PM ET) Add Compare Share Share Competitors Stock AnalysisChartCompetitorsHeadlines CTX vs. VIR, ZOM, IN, META, DB, LABS, CWEB, NRTH, MRV, and WLLWShould you be buying Crescita Therapeutics stock or one of its competitors? The main competitors of Crescita Therapeutics include Viridium Pacific Group (VIR), Zomedica Pharmaceuticals Corp. (ZOM.V) (ZOM), InMed Pharmaceuticals (IN), Meta Growth (META), Decibel Cannabis (DB), MediPharm Labs (LABS), Charlotte's Web (CWEB), 48North Cannabis (NRTH), Nuvo Pharmaceuticals (MRV), and Willow Biosciences (WLLW). These companies are all part of the "drug manufacturers - specialty & generic" industry. Crescita Therapeutics vs. Viridium Pacific Group Zomedica Pharmaceuticals Corp. (ZOM.V) InMed Pharmaceuticals Meta Growth Decibel Cannabis MediPharm Labs Charlotte's Web 48North Cannabis Nuvo Pharmaceuticals Willow Biosciences Viridium Pacific Group (CVE:VIR) and Crescita Therapeutics (TSE:CTX) are both small-cap medical companies, but which is the superior stock? We will compare the two businesses based on the strength of their analyst recommendations, profitability, institutional ownership, media sentiment, dividends, community ranking, earnings, valuation and risk. Does the media refer more to VIR or CTX? In the previous week, Viridium Pacific Group's average media sentiment score of 0.00 equaled Crescita Therapeutics'average media sentiment score. Company Overall Sentiment Viridium Pacific Group Neutral Crescita Therapeutics Neutral Does the MarketBeat Community prefer VIR or CTX? Crescita Therapeutics received 20 more outperform votes than Viridium Pacific Group when rated by MarketBeat users. However, 83.33% of users gave Viridium Pacific Group an outperform vote while only 67.42% of users gave Crescita Therapeutics an outperform vote. CompanyUnderperformOutperformViridium Pacific GroupOutperform Votes4083.33% Underperform Votes816.67%Crescita TherapeuticsOutperform Votes6067.42% Underperform Votes2932.58% Which has higher valuation and earnings, VIR or CTX? Crescita Therapeutics has higher revenue and earnings than Viridium Pacific Group. Crescita Therapeutics is trading at a lower price-to-earnings ratio than Viridium Pacific Group, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioViridium Pacific GroupC$1.09M34.46-C$12.64M-C$0.13-2.97Crescita TherapeuticsC$16.84M0.64-C$2.98M-C$0.15-3.73 Is VIR or CTX more profitable? Viridium Pacific Group has a net margin of 0.00% compared to Crescita Therapeutics' net margin of -17.72%. Viridium Pacific Group's return on equity of 0.00% beat Crescita Therapeutics' return on equity.Company Net Margins Return on Equity Return on Assets Viridium Pacific GroupN/A N/A N/A Crescita Therapeutics -17.72%-15.79%-8.26% SummaryViridium Pacific Group beats Crescita Therapeutics on 7 of the 10 factors compared between the two stocks. Ad StocksToTradeAfter New Years, price goes back up 4,800%When was the last time you bought something for a buck? I don’t even think you can buy anything at McDonalds for a dollar anymore!Click here to review Tim’s special Holiday offer before it’s too late. Get Crescita Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for CTX and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of TSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart CTX vs. The Competition Export to ExcelMetricCrescita TherapeuticsDrug Manufacturers IndustryMedical SectorTSE ExchangeMarket CapC$10.85MC$1.18BC$5.23BC$6.09BDividend YieldN/A3.04%5.12%5.40%P/E Ratio-3.73135.1487.8525.75Price / Sales0.642,547.121,168.851,278.31Price / Cash1.2010.2543.2382.48Price / Book0.633.094.833.13Net Income-C$2.98MC$152.21MC$120.63MC$294.08M7 Day Performance-1.75%1.97%2.84%1.47%1 Month Performance-12.50%-1.86%19.70%14.00%1 Year Performance31.76%101.16%30.58%34.83% Crescita Therapeutics Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)CTXCrescita TherapeuticsN/AC$0.56-5.1%N/A+31.8%C$10.85MC$16.84M-3.7362Gap DownHigh Trading VolumeVIRViridium Pacific GroupN/AC$0.38+5.6%N/A+0.0%C$37.52MC$1.09M-2.97580Gap UpZOMZomedica Pharmaceuticals Corp. (ZOM.V)N/AC$0.29-6.6%N/A+0.0%C$36.73MN/A-2.6150Gap DownINInMed PharmaceuticalsN/AC$4.19-1.6%N/AN/AC$33.73MC$574,677.00-2.7712METAMeta GrowthN/AC$0.14flatN/A+0.0%C$33.14MC$60.96M-0.6686,500Gap DownDBDecibel Cannabis1.2234 of 5 starsC$0.07flatC$0.28+304.8%-44.4%C$28.63MC$105.60M-7.0083,000LABSMediPharm LabsN/AC$0.07+18.2%N/A+8.3%C$26.72MC$37.76M-1.63130High Trading VolumeCWEBCharlotte's WebN/AC$0.15flatN/A-49.1%C$23.63MC$54.55M-0.38164Gap DownNRTH48North CannabisN/AC$0.07-6.7%N/A+0.0%C$15.76MC$18.90M-0.3047MRVNuvo PharmaceuticalsN/AC$1.35flatN/AN/AC$15.38MC$72.42M-19.29N/AWLLWWillow BiosciencesN/AC$0.08flatN/A-40.0%C$10.82MC$1.84M-1.2519Gap UpHigh Trading Volume Related Companies and Tools Related Companies VIR Alternatives ZOM Alternatives IN Alternatives META Alternatives DB Alternatives LABS Alternatives CWEB Alternatives NRTH Alternatives MRV Alternatives WLLW Alternatives Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (TSE:CTX) was last updated on 12/25/2024 by MarketBeat.com Staff From Our PartnersAmazon coin set to soar 25X – starting December 16th?This tiny 3-cent crypto just partnered with one of the biggest companies in the world… Amazon. And one team...True Market Insiders | SponsoredDid You See Trump’s Bombshell Exec. Order 001?Biden broke it... Now Trump is going to fix it. Starting with "Exec. Order 001."Banyan Hill Publishing | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | SponsoredElon Musk’s chilling warning for humanityThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | SponsoredVladimir Lenin was right…The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Crescita Therapeutics Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Crescita Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
